Skip to search formSkip to main contentSkip to account menu

tetrahydroneopterin

Known as: 2-amino-5,6,7,8-tetrahydro-6-(1,2,3-trihydroxypropyl)-4(1H)-pteridinone, 5,6,7,8-tetrahydroneopterin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Background— Heart failure with preserved ejection fraction is 1 consequence of hypertension and is caused by impaired cardiac… 
Highly Cited
2008
Highly Cited
2008
Highly Cited
2005
Highly Cited
2005
Cardiac pressure load stimulates hypertrophy, often leading to chamber dilation and dysfunction. ROS contribute to this process… 
Highly Cited
2000
Highly Cited
2000
Conditions associated with impaired nitric oxide (NO) activity and accelerated atherosclerosis have been shown to be associated… 
1993
1993
The protective effect of the reduced form of neopterin, 5,6,7,8-tetrahydroneopterin (NPH4), against the cardiotoxicity of… 
Highly Cited
1990
1984
1984
Highly Cited
1980
Highly Cited
1980